Stock Scorer

Novartis AG ADR (NVS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 5B 10B 15B Q2 '17: 12.2B Q2 '18: 11.4B Q2 '19: 11.8B Q2 '20: 11.3B Q2 '21: 13B Q2 '22: 12.8B Q2 '23: 11.4B Q2 '24: 12.5B Q2 '25: 14.1B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Gross Profit Quarterly

0 4B 8B 12B Q2 '17: 8.2B Q2 '18: 8.1B Q2 '19: 8.6B Q2 '20: 8.2B Q2 '21: 9.4B Q2 '22: 9.3B Q2 '23: 8.4B Q2 '24: 9.7B Q2 '25: 11.5B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Operating Income Quarterly

0 2B 4B 6B Q2 '17: 2.3B Q2 '18: 2.4B Q2 '19: 2.7B Q2 '20: 2.4B Q2 '21: 3.5B Q2 '22: 2.2B Q2 '23: 2.8B Q2 '24: 4B Q2 '25: 4.9B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Net Income Quarterly

0 3B 6B 9B Q2 '17: 2B Q2 '18: 7.8B Q2 '19: 6.8B Q2 '20: 1.9B Q2 '21: 2.9B Q2 '22: 1.7B Q2 '23: 2.3B Q2 '24: 3.2B Q2 '25: 4B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Cost of Revenue Quarterly

0 1.5B 3B 4.5B Q2 '17: 4.3B Q2 '18: 3.6B Q2 '19: 3.4B Q2 '20: 3.4B Q2 '21: 3.9B Q2 '22: 3.8B Q2 '23: 3.3B Q2 '24: 3.2B Q2 '25: 3.3B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Operating Cash Flow Quarterly

0 2.5B 5B 7.5B Q2 '17: 3.6B Q2 '18: 3.9B Q2 '19: 3.1B Q2 '20: 4B Q2 '21: 4.1B Q2 '22: 3.8B Q2 '23: 3.6B Q2 '24: 4.9B Q2 '25: 6.7B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Free Cash Flow Quarterly

0 2.5B 5B 7.5B Q2 '17: 3.2B Q2 '18: 3.7B Q2 '19: 2.8B Q2 '20: 3.7B Q2 '21: 3.8B Q2 '22: 3.5B Q2 '23: 3.4B Q2 '24: 4.6B Q2 '25: 6.3B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 900M 1.8B 2.7B Q2 '17: 2.4B Q2 '18: 2.3B Q2 '19: 2.3B Q2 '20: 2.3B Q2 '21: 2.3B Q2 '22: 2.2B Q2 '23: 2.1B Q2 '24: 2B Q2 '25: 2B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS Annual

0.00 4.00 8.00 12.00 FY21: 10.63 FY22: 3.17 FY23: 7.10 FY24: 5.87 FY25: 7.15 FY21 FY22 FY23 FY24 FY25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.